These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 90975)

  • 1. Platelets, endothelium, and renal disease.
    Lancet; 1979 Oct; 2(8148):890-1. PubMed ID: 90975
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Brain MC; Neame PB
    Semin Thromb Hemost; 1982 Jul; 8(3):186-97. PubMed ID: 6753155
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelets and renal disease. A review.
    Jørgensen KA
    Dan Med Bull; 1981 Aug; 28(3):116-22. PubMed ID: 7023860
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of the determination of prostacyclin metabolism in the management of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Túri S; Beattie JT
    Orv Hetil; 1986 Jul; 127(29):1747-51. PubMed ID: 3526247
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostacyclin deficiency in thrombotic microangiopathy.
    Remuzzi G; Imberti L; de Gaetano G
    Lancet; 1981 Dec 19-26; 2(8260-61):1422-3. PubMed ID: 6118791
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).
    Moake JL
    Prog Clin Biol Res; 1990; 337():135-40. PubMed ID: 2191307
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Kwaan HC; Soff GA
    Semin Hematol; 1997 Apr; 34(2):159-66. PubMed ID: 9109218
    [No Abstract]   [Full Text] [Related]  

  • 8. von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL; McPherson PD
    Transfus Med Rev; 1990 Apr; 4(2):163-8. PubMed ID: 2134624
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostacyclin in thrombotic microangiopathy.
    Remuzzi G; Zoja C; Rossi EC
    Semin Hematol; 1987 Apr; 24(2):110-8. PubMed ID: 3299719
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent observations on the pathophysiology of thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL
    Hematol Pathol; 1990; 4(4):197-201. PubMed ID: 2074261
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelets and the hemolytic-uremic syndrome.
    Rossi EC; Carone FA; del Greco F
    Ann Clin Lab Sci; 1981; 11(3):269-73. PubMed ID: 7018371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
    Boctor FN
    Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?
    Remuzzi G; Misiani R; Marchesi D; Livio M; Mecca G; de Gaetano G; Donati MB
    Lancet; 1978 Oct; 2(8095):871-2. PubMed ID: 81415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor in thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Thromb Haemost; 1999 Aug; 82(2):592-600. PubMed ID: 10605756
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of thrombocytopenic thrombotic purpura].
    Corte Buelga JR; Rodríguez Vicente P; García Gala JM; Alonso García AM; Martínez Revuelta E
    Sangre (Barc); 1997 Feb; 42(1):53-61. PubMed ID: 9229804
    [No Abstract]   [Full Text] [Related]  

  • 16. Unintentional platelet removal by plasmapheresis.
    Perdue JJ; Chandler LK; Vesely SK; Duvall DS; Gilcher RO; Smith JW; George JN
    J Clin Apher; 2001; 16(2):55-60. PubMed ID: 11746529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of the hemolytic-uremic syndrome and thrombotic thrombopenic purpura].
    Villegas A; Alvarez-Sala JL; Espinós D
    Sangre (Barc); 1983; 28(5):635-41. PubMed ID: 6364423
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in the treatment of TTP.
    Taft EG
    Prog Clin Biol Res; 1990; 337():151-5. PubMed ID: 2191309
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasmapheresis in the treatment of glomerulonephritis: indications and complications.
    Sanz-Guajardo D
    Am J Kidney Dis; 2000 Aug; 36(2):liv-lvi. PubMed ID: 10970237
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood.
    Monnens L; van de Meer W; Langenhuysen C; van Munster P; van Oostrom C
    Clin Nephrol; 1985 Sep; 24(3):135-7. PubMed ID: 4042442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.